S273: LONG-TERM ERYTHROID RESPONSE DATA FROM PATIENTS (PTS) WITH NON-TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA (NTDT) RECEIVING LUSPATERCEPT IN THE BEYOND TRIAL

• Ali T. Taher,
• Vip Viprakasit,
• Maria Domenica Cappellini,
• Antonio Giulio Piga,
• John B. Porter,
• Thomas D. Coates,
• Khaled M. Musallam,
• Gian Luca Forni,
• Jeevan K. Shetty,
• Marija Bosilkovska Weisskopf,
• Richard Wei,
• Wen-Ling Kuo,
• Antonis Kattamis

Affiliations

Ali T. Taher

1 American University of Beirut Medical Center, Department of Internal Medicine, Beirut, Lebanon

Vip Viprakasit

2 Siriraj Research Hospital, Mahidol University, Bangkok, Thailand

Maria Domenica Cappellini

3 Fondazione IRCCS Ca’ Granda Policlinico Hospital, University of Milan, Milan, Italy

Antonio Giulio Piga

4 University of Turin, Turin, Italy

John B. Porter

5 University College London, University College London Hospitals, London, United Kingdom

Thomas D. Coates

6 Cancer and Blood Disease Institute, Children’s Hospital Los Angeles, Los Angeles, CA, United States

Khaled M. Musallam

8 Thalassemia Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates

Gian Luca Forni

10 Centro della Microcitemia e Anemie Congenite e del Dismetabolismo del Ferro, Ospedale Galliera, Genoa, Italy

Jeevan K. Shetty

11 Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland

Marija Bosilkovska Weisskopf

11 Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland

Richard Wei

12 Bristol Myers Squibb, Princeton, NJ, United States

Wen-Ling Kuo

12 Bristol Myers Squibb, Princeton, NJ, United States

Antonis Kattamis

13 National and Kapodistrian University of Athens, First Department of Pediatrics, Athens, Greece